RE:RE:Is U.S. FDA the centre of the biotech universe?That's why Ipsen is our best bet to recover value. They own the rights to Europe and they are on the hook financially to see this through to approval if they choose to carry on. If they see the value in doing this it also makes sense to buy the company and have full control of the science and manufacturing. If Ipsen believes in this they will not want anyone else to buy it.
No one here seems to be catching on to comments around the push in Europe for MCNA, I was asked not to share and I won't but do your research focused on Kamat.